Skip to main content
. 2023 Jan 17;41(10):1841–1848. doi: 10.1200/JCO.22.01499

FIG A1.

FIG A1.

Independent calibration of SETER/PR and SET2,3 indices from the diagnostic assay platform (Quantigene) to whole-transcriptome RNAseq in 106 formalin-fixed paraffin-embedded tumor samples of breast cancer: (A) correlation of the SETER/PR index before calibration and (B) correlation of the SET2,3 index after calibration using linear regression. Black horizontal and vertical lines at 2.1 indicate the threshold between high and low SET2,3. R, Pearson correlation coefficient; RNAseq, RNA sequencing; SET2,3, sensitivity to endocrine therapy index; SETER/PR, sensitivity to endocrine therapy index of transcription related to estrogen and progesterone receptors.